Madrigal Pharmaceuticals's total assets for Q4 2024 were $1.04B, a decrease of -2.89% from the previous quarter. MDGL total liabilities were $287.86M for the fiscal quarter, a -2.78% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.